Healthconn Corp.
Healthconn Corp. engages in the health services management in Taiwan and China. The company engages in the provision of health promotion consulting services, precision medicine health management services; genetic testing; and sales of molecular biology, genetics, microbial life science testing, precision instruments, and reagents. It also offers diagnostic solutions, including microbiology, total… Read more
Healthconn Corp. (6665) - Net Assets
Latest net assets as of December 2023: NT$916.46 Million TWD
Based on the latest financial reports, Healthconn Corp. (6665) has net assets worth NT$916.46 Million TWD as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$1.54 Billion) and total liabilities (NT$622.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$916.46 Million |
| % of Total Assets | 59.55% |
| Annual Growth Rate | 6.0% |
| 5-Year Change | -17.6% |
| 10-Year Change | N/A |
| Growth Volatility | 15.12 |
Healthconn Corp. - Net Assets Trend (2016–2023)
This chart illustrates how Healthconn Corp.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Healthconn Corp. (2016–2023)
The table below shows the annual net assets of Healthconn Corp. from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | NT$916.46 Million | -2.74% |
| 2022-12-31 | NT$942.32 Million | +2.19% |
| 2021-12-31 | NT$922.14 Million | -6.93% |
| 2020-12-31 | NT$990.76 Million | -10.92% |
| 2019-12-31 | NT$1.11 Billion | +13.98% |
| 2018-12-31 | NT$975.85 Million | +18.62% |
| 2017-12-31 | NT$822.68 Million | +34.99% |
| 2016-12-31 | NT$609.45 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Healthconn Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 15.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$309.00 Million | 33.72% |
| Common Stock | NT$453.50 Million | 49.48% |
| Other Comprehensive Income | NT$118.57 Million | 12.94% |
| Other Components | NT$35.38 Million | 3.86% |
| Total Equity | NT$916.46 Million | 100.00% |
Healthconn Corp. Competitors by Market Cap
The table below lists competitors of Healthconn Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Asia Precision Public Company Limited
BK:APCS
|
$12.58 Million |
|
Thai Rubber Latex Group Public Company Limited
BK:TRUBB
|
$12.58 Million |
|
Laredo Oil Inc
PINK:LRDC
|
$12.59 Million |
|
Blue Sky Uranium Corp
OTCQB:BKUCF
|
$12.59 Million |
|
iZafe Group AB Series B
ST:IZAFE-B
|
$12.58 Million |
|
AlzeCure Pharma
ST:ALZCUR
|
$12.56 Million |
|
Rocky Mountain Chocolate Factory
NASDAQ:RMCF
|
$12.56 Million |
|
Wellysun Inc
TW:6988
|
$12.56 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Healthconn Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 942,319,000 to 916,456,000, a change of -25,863,000 (-2.7%).
- Net income of 2,357,000 contributed positively to equity growth.
- Dividend payments of 20,679,000 reduced retained earnings.
- Other comprehensive income decreased equity by 21,349,001.
- Other factors increased equity by 13,808,001.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$2.36 Million | +0.26% |
| Dividends Paid | NT$20.68 Million | -2.26% |
| Other Comprehensive Income | NT$-21.35 Million | -2.33% |
| Other Changes | NT$13.81 Million | +1.51% |
| Total Change | NT$- | -2.74% |
Book Value vs Market Value Analysis
This analysis compares Healthconn Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.52x to 1.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | NT$13.32 | NT$20.20 | x |
| 2017-12-31 | NT$17.89 | NT$20.20 | x |
| 2018-12-31 | NT$21.02 | NT$20.20 | x |
| 2019-12-31 | NT$24.11 | NT$20.20 | x |
| 2020-12-31 | NT$21.73 | NT$20.20 | x |
| 2021-12-31 | NT$20.35 | NT$20.20 | x |
| 2022-12-31 | NT$20.77 | NT$20.20 | x |
| 2023-12-31 | NT$20.20 | NT$20.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Healthconn Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.26%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.19%
- • Asset Turnover: 0.82x
- • Equity Multiplier: 1.68x
- Recent ROE (0.26%) is below the historical average (15.67%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 24.61% | 32.57% | 0.57x | 1.32x | NT$89.01 Million |
| 2017 | 28.30% | 21.03% | 0.90x | 1.50x | NT$150.59 Million |
| 2018 | 27.77% | 15.67% | 1.23x | 1.44x | NT$173.43 Million |
| 2019 | 25.73% | 57.62% | 0.35x | 1.29x | NT$175.00 Million |
| 2020 | 11.91% | 38.92% | 0.22x | 1.42x | NT$18.96 Million |
| 2021 | 4.06% | 2.75% | 0.77x | 1.92x | NT$-54.78 Million |
| 2022 | 2.70% | 1.65% | 0.93x | 1.77x | NT$-68.79 Million |
| 2023 | 0.26% | 0.19% | 0.82x | 1.68x | NT$-89.29 Million |
Industry Comparison
This section compares Healthconn Corp.'s net assets metrics with peer companies in the Healthcare Plans industry.
No peer company data available for comparison.